Press "Enter" to skip to content

New patent for Exeltis Usa drug SLYND

0
Copyright © DrugPatentWatch. Originally published at New patent for Exeltis Usa drug SLYND

Annual Drug Patent Expirations for SLYND
Annual Drug Patent Expirations for SLYND

Slynd is a drug marketed by Exeltis Usa Inc and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.

SLYND drug price trends.

This drug has forty-three patent family members in twenty-eight countries.

The generic ingredient in SLYND is drospirenone. One supplier is listed for this compound. Additional details are available on the drospirenone profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Exeltis Usa drug SLYND
Online Certificate Course

Decision-Making for Generic Drug Entry & Branded Drug Lifecycle Management

  • When will key drug patents expire?
  • How can I find, evaluate, and plan for generic market entry opportunities?
  • How can I find proprietary out-of-court settlements and deal terms?
DrugPatentWatch - Make Better Decisions